5:19 PM
 | 
Mar 19, 2007
 |  BC Extra  |  Financial News

Spaltudaq raises $29 million

Antibody company Spaltudaq (Seattle, Wash.) raised $29 million in a series B round led by Arch Venture Partners and new...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >